PF-Atlas › Clinical Trials › NCT06323876
The Role of Quantitative CT and Radiomic Biomarkers for Precision Medicine in Pulmonary Fibrosis
HRCT · Not specified
Registry ID
NCT06323876
Phase
Not specified
Status
Recruiting
Drug / intervention
HRCT
Sponsor
University of Virginia
Start
2024-06-20
Enrollment
160
Locations
1
About this trial
This observational study involves obtaining 2 chest CT scans; a historical baseline CT within ±1 year of enrollment into PRECISIONS, and a follow-up CT (either historical or prospective) 12 months ± 180 days after the baseline CT. Many IPF patients will have a CT scan every 12 months for disease monitoring and cancer screening. Participants will have the option to share historical CTs only or they can choose to have a research CT done for the follow-up scan, if a scan for clinical purposes is not available.
Explore related
Medical disclaimer. This page summarizes public trial data for NCT06323876 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.